Resum
Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients. © Georg Thieme Verlag KG Stuttgart.
| Idioma original | Anglès |
|---|---|
| Pàgines (de-a) | 117-118 |
| Revista | Pharmacopsychiatry |
| Volum | 39 |
| Número | 3 |
| DOIs | |
| Estat de la publicació | Publicada - 1 de maig 2006 |
Fingerprint
Navegar pels temes de recerca de 'Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report'. Junts formen un fingerprint únic.Com citar-ho
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver